WHO COVID-19 therapeutic guidelines – authors' reply

Similar Items

• Guidelines should not pool evidence from uncomplicated and severe COVID-19
  by: White, NJ, et al.
  Published: (2021)
• The consequence of COVID-19 on the global supply of medical products: Why Indian generics matter for the world?
  by: Guerin, PJ, et al.
  Published: (2020)
• Definitions matter: heterogeneity of COVID-19 disease severity criteria and incomplete reporting compromise meta-analysis
  by: Guérin, PJ, et al.
  Published: (2022)
• Comparison of WHO versus national COVID-19 therapeutic guidelines across the world: not exactly a perfect match
  by: Cokljat, M, et al.
  Published: (2024)
• The consequence of COVID-19 on the global supply of medical products: Why Indian generics matter for the world? [version 1; peer review: 3 approved, 1 approved with reservations]
  by: Philippe J Guerin, et al.
  Published: (2020-04-01)